Literature DB >> 16253802

Arterial thromboembolic complications in critically ill children.

Manuela Albisetti1, Markus Schmugge, Rabea Haas, Boris P Eckhardt, Urs Bauersfeld, Oskar Baenziger, Maja I Hug.   

Abstract

PURPOSE: To evaluate incidence and characteristics of arterial thromboembolic complications in critically ill children.
MATERIALS AND METHODS: Hospital records of all consecutive patients with arterial thromboembolic events (ATEs) occurring in the pediatric intensive care unit (PICU) from January 1997 to August 2001 were reviewed. Data collected included demographics and location, treatment modalities and outcome of ATEs.
RESULTS: Fifty-four ATEs in 51 children (median age, 14 days) were identified, reflecting an incidence of 1.2% of all PICU patients. Arterial thromboembolic events were located in peripheral arteries in 52 (96%) cases and were associated with indwelling arterial catheters (n=26) or cardiac catheterization (n=26). The remaining 2 ATEs were located in the left ventricle and cerebral arteries, respectively. Therapy consisted of heparin (n=51), thrombolysis (n=22), oral anticoagulation (n=12), and aspirin (n=34). Complete resolution was noted in 33 (70%), partial resolution in 10 (21%), and no resolution in 4 (8.5%) cases. Bleeding complications occurred in 1 patient treated with heparin and in 12 (54%) of the 22 patients receiving thrombolytic therapy.
CONCLUSIONS: Arterial thromboembolic events are frequent complications of PICU, particularly affecting neonates, and mostly associated with catheters. Studies to determine safe and effective prophylactic and treatment modalities of ATEs in children are required.

Entities:  

Mesh:

Year:  2005        PMID: 16253802     DOI: 10.1016/j.jcrc.2005.05.005

Source DB:  PubMed          Journal:  J Crit Care        ISSN: 0883-9441            Impact factor:   3.425


  6 in total

1.  Antithrombotic therapy in neonates and children: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Paul Monagle; Anthony K C Chan; Neil A Goldenberg; Rebecca N Ichord; Janna M Journeycake; Ulrike Nowak-Göttl; Sara K Vesely
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

2.  Aortic arch thrombosis in the neonate.

Authors:  Yuichiro Hashida; Satoshi Yasukochi; Kiyohiro Takigiku; Tesshu Otagiri; Nao Inoue; Yusuke Nakano; Kohta Takei; Yoshiyuki Maekawa; Kentaro Umezu; Takahiko Sakamoto; Yorikazu Harada
Journal:  J Echocardiogr       Date:  2013-02-03

3.  Enoxaparin therapy for arterial thrombosis in infants with congenital heart disease.

Authors:  Joe Bontadelli; Alexander Moeller; Markus Schmugge; Thomas Schraner; Oliver Kretschmar; Urs Bauersfeld; Vera Bernet-Buettiker; Manuela Albisetti
Journal:  Intensive Care Med       Date:  2007-06-07       Impact factor: 17.440

4.  Lack of difference between continuous versus intermittent heparin infusion on maintenance of intra-arterial catheter in postoperative pediatric surgery: a randomized controlled study.

Authors:  Maria Carolina Witkowski; Maria Antonieta P de Moraes; Cora Maria F Firpo
Journal:  Rev Paul Pediatr       Date:  2013-12

5.  Thrombolysis Using Tissue Plasminogen Activator: Experience from a Critical Care Setting.

Authors:  Amna Afzal Saeed; Qalab Abbas; Sidra Ishaque; Bushra Saeed; Anwar Ul Haque
Journal:  Indian J Hematol Blood Transfus       Date:  2018-03-20       Impact factor: 0.900

6.  Different unfractionated heparin doses for preventing arterial thrombosis in children undergoing cardiac catheterization.

Authors:  Maria L Avila; Prakeshkumar S Shah; Leonardo R Brandão
Journal:  Cochrane Database Syst Rev       Date:  2020-02-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.